Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medrol dosepaks in rhinoplasty
NCT06483204Phase 4Withdrawn
- Sponsor
- Vanderbilt University Medical Center
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of methylprednisolone in postoperative pain, postoperative nausea and vomiting (PONV), edema, ecchymosis, sponsored by Vanderbilt University Medical Center. Planned start Jan 2026; status: withdrawn.
02
Drugs
methylprednisolone
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)edemaecchymosis
Beyond the preview
Go deeper on NCT06483204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06483204.